Cubist Systematic Strategies, LLC Dr Reddys Laboratories LTD Transaction History

Cubist Systematic Strategies, LLC

$17.3 Billion
Q1 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 3,682 shares of RDY stock, worth $280,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,682

Previous 7,866 53.19%

Holding current value

$280,531

Previous $547,000 50.64%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$67.36 - $77.59 $281,834 - $324,636	-4,184 Reduced 53.19%	3,682 $270,000
Q4 2023 Feb 14, 2024	SELL	$64.27 - $69.9 $8.3 Million - $9.03 Million	-129,184 Reduced 94.26%	7,866 $547,000
Q3 2023 Nov 14, 2023	BUY	$61.9 - $72.77 $5.23 Million - $6.14 Million	84,429 Added 160.45%	137,050 $9.16 Million
Q2 2023 Aug 14, 2023	SELL	$53.34 - $63.11 $555,429 - $657,164	-10,413 Reduced 16.52%	52,621 $3.32 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $1.54 Million - $1.7 Million	29,834 Added 89.86%	63,034 $3.59 Million

Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $1.15 Million - $1.29 Million	22,494 Added 210.11%	33,200 $1.72 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $909,277 - $1.04 Million	-18,222 Reduced 62.99%	10,706 $560,000
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $1.15 Million - $1.34 Million	23,100 Added 396.36%	28,928 $1.6 Million
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $105,373 - $142,440	2,183 Added 59.89%	5,828 $325,000
Q4 2021 Feb 14, 2022	BUY	$59.5 - $67.25 $216,877 - $245,126	3,645 New	3,645 $238,000
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $521,932 - $623,428	-8,402 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$57.98 - $73.08 $487,147 - $614,018	8,402 New	8,402 $516,000
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $311,046 - $354,168	-4,968 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$51.39 - $72.41 $186,751 - $263,137	-3,634 Reduced 42.25%	4,968 $346,000
Q2 2020 Aug 14, 2020	BUY	$39.55 - $54.65 $340,209 - $470,099	8,602 New	8,602 $456,000
Q1 2020 May 15, 2020	SELL	$34.75 - $45.85 $577,093 - $761,430	-16,607 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.66 - $41.78 $549,863 - $626,658	14,999 Added 932.77%	16,607 $674,000
Q3 2019 Nov 14, 2019	SELL	$34.82 - $39.26 $365,435 - $412,033	-10,495 Reduced 86.71%	1,608 $61,000
Q2 2019 Aug 14, 2019	BUY	$36.05 - $42.76 $436,313 - $517,524	12,103 New	12,103 $453,000
Q1 2019 May 15, 2019	SELL	$35.77 - $40.57 $9,157 - $10,385	-256 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$31.89 - $38.44 $8,163 - $9,840	256 New	256 $10,000
Q3 2018 Nov 14, 2018	SELL	$29.25 - $36.73 $392,886 - $493,357	-13,432 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$28.49 - $35.06 $133,846 - $164,711	4,698 Added 53.79%	13,432 $433,000
Q1 2018 May 15, 2018	SELL	$31.93 - $39.54 $8,142 - $10,082	-255 Reduced 2.84%	8,734 $286,000
Q4 2017 Feb 14, 2018	BUY	$34.15 - $37.62 $306,974 - $338,166	8,989	8,989 $338,000

Others Institutions Holding RDY

# of Institutions

242

Shares Held

23.6M

Call Options Held

25.2K

Put Options Held

8.5K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Dr Reddys Laboratories LTD Transaction History